Richards A, van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D, Liszewski MK, Barilla-Labarca ML, Terwindt GM, Kasai Y, McLellan M, Grand MG, Vanmolkot KR, de Vries B, Wan J, Kane MJ, Mamsa H, Schafer R, Stam AH, Haan J, de Jong PT, Storimans CW, van Schooneveld MJ, Oosterhuis JA, Gschwendter A, Dichgans M, Kotschet KE, Hodgkinson S, Hardy TA, Delatycki MB, Hajj-Ali RA, Kothari PH, Nelson SF, Frants RR, Baloh RW, Ferrari MD, Atkinson JP

C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy.

Nat Genet 39:1068-70 (2007)
DOI:10.1038/ng2082

Lehtinen DA, Harvey S, Mulcahy MJ, Hollis T, Perrino FW

The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.

J Biol Chem 283:31649-56 (2008)
DOI:10.1074/jbc.M806155200

Stetson DB, Ko JS, Heidmann T, Medzhitov R

Trex1 prevents cell-intrinsic initiation of autoimmunity.

Cell 134:587-98 (2008)
DOI:10.1016/j.cell.2008.06.032